Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Renqing Mangjue is a traditional Tibetan medicine (TTM) formulation developed and marketed by Gansu Qizheng Tibetan Medicine. It belongs to the category of 'Precious Pills' (Rinchen Tselwa), which are highly regarded in Tibetan medical practice for their complex compositions and potent therapeutic effects. The formulation consists of a diverse mixture of herbal and mineral ingredients processed according to traditional methods. It is primarily indicated for detoxification and the treatment of various 'poisoning' syndromes, including those resulting from environmental toxins, food, or chronic metabolic waste. Additionally, it is used to treat chronic gastrointestinal disorders such as gastritis and peptic ulcers, as well as liver diseases and rheumatoid arthritis. As a traditional multi-component therapy, its mechanism involves the synergistic action of its constituents to balance the body's internal systems rather than targeting a single biological pathway. It is an approved pharmaceutical product in China, administered orally in capsule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on renqing mangjue (Gansu Qizheng Tibetan Medicine).